The NHLBI Small Market Awards support Phase II SBIR or STTR awardees developing technologies for rare diseases or young pediatric populations. This grant aims to validate technologies for further development with private funding post-NHLBI support. Applicants must demonstrate independent third-party funding matching at least one-third of NHLBI funds. Projects should target Federal regulatory approval, spanning preclinical to clinical stages with optional clinical trials. Applications must focus on NHLBI mission-related technologies. Closing date: Jan 23, 2018.
Opportunity ID: 283107
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-17-012 |
| Funding Opportunity Title: | Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Apr 18, 2016 |
| Last Updated Date: | Jan 24, 2018 |
| Original Closing Date for Applications: | Jun 20, 2018 |
| Current Closing Date for Applications: | Jan 23, 2018 |
| Archive Date: | Feb 22, 2018 |
| Estimated Total Program Funding: | $2,000,000 |
| Award Ceiling: | $3,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR or STTR awardees developing NHLBI mission-related technologies that address a rare disease or young pediatric populations. The goal of this FOA is for these technologies to be further validated so that development can continue with private funding after NHLBI support ends. Applicants must submit a Commercialization Plan that includes details on any independent third-party funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will be equal to or greater than one-third of the NHLBI funds being requested throughout the project period. Projects proposed in response to this FOA must require eventual Federal regulatory approval/clearance, and may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate, but are not required. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-17-012.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Updated expiration date in accordance with NOT-HL-18-584 | Jan 24, 2018 | |
| Jan 24, 2018 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-17-012 |
| Funding Opportunity Title: | Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Apr 18, 2016 |
| Last Updated Date: | Jan 24, 2018 |
| Original Closing Date for Applications: | Jun 20, 2018 |
| Current Closing Date for Applications: | Jan 23, 2018 |
| Archive Date: | Feb 22, 2018 |
| Estimated Total Program Funding: | $2,000,000 |
| Award Ceiling: | $3,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR or STTR awardees developing NHLBI mission-related technologies that address a rare disease or young pediatric populations. The goal of this FOA is for these technologies to be further validated so that development can continue with private funding after NHLBI support ends. Applicants must submit a Commercialization Plan that includes details on any independent third-party funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will be equal to or greater than one-third of the NHLBI funds being requested throughout the project period. Projects proposed in response to this FOA must require eventual Federal regulatory approval/clearance, and may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate, but are not required. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-17-012.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-17-012 |
| Funding Opportunity Title: | Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 24, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jun 20, 2018 |
| Archive Date: | Jul 21, 2018 |
| Estimated Total Program Funding: | $2,000,000 |
| Award Ceiling: | $3,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR or STTR awardees developing NHLBI mission-related technologies that address a rare disease or young pediatric populations. The goal of this FOA is for these technologies to be further validated so that development can continue with private funding after NHLBI support ends. Applicants must submit a Commercialization Plan that includes details on any independent third-party funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will be equal to or greater than one-third of the NHLBI funds being requested throughout the project period. Projects proposed in response to this FOA must require eventual Federal regulatory approval/clearance, and may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate, but are not required. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-17-012.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00222862 | May 20, 2016 | Jan 25, 2018 | View |
Package 1
Mandatory forms
283107 RR_SF424_2_0-2.0.pdf
283107 PHS398_CoverPageSupplement_3_0-3.0.pdf
283107 RR_OtherProjectInfo_1_3-1.3.pdf
283107 PerformanceSite_2_0-2.0.pdf
283107 RR_KeyPersonExpanded_2_0-2.0.pdf
283107 RR_Budget_1_3-1.3.pdf
283107 PHS398_ResearchPlan_3_0-3.0.pdf
283107 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
283107 RR_SubawardBudget30_1_3-1.3.pdf
283107 PHS_Inclusion_Enrollment_Report-1.0.pdf
283107 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
